Modern Healthcare Technology Holdings Limited (0919) AI Stock Analysis

• Market Cap: HK$85.93M
• Dividend Yield: N/A
• Average Volume (3M): 71.60K
• Price to Earnings (P/E): 4.8
• Beta (1Y): -0.03
• Revenue Growth: -3.40%
• EPS Growth: 515.63%
• Country: HK
• Employees: 850
• Sector: Consumer Cyclical
• Sector Strength: 84
• Industry: Personal Products & Services
• EPS (TTM): <0.01
• Shares Outstanding: 904,483,950
• 10 Day Avg. Volume: 65,200
• 30 Day Avg. Volume: 71,600
• PEG Ratio: 0.28
• Price to Book (P/B): 0.36
• Price to Sales (P/S): 0.15
• P/FCF Ratio: 0.50
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 59 Neutral
• Price Target: HK$0.11 ▲(38.75% Upside)

The score is primarily held back by weak financial performance—declining revenue and negative profitability metrics—despite improved cash flow and leverage. Technicals are supportive with an established uptrend, but overbought RSI raises near-term risk. Valuation is a modest positive due to the low P/E, though no dividend yield is provided.

Positive Factors

Cash Flow Generation

Strong free cash flow growth suggests the company can efficiently fund operations and investments, enhancing long-term financial stability.

Leverage Management

Improved leverage management reduces financial risk and increases the company's ability to invest in growth opportunities.

Gross Profit Margins

Healthy gross profit margins indicate strong pricing power and cost management, supporting long-term profitability potential.

Negative Factors

Revenue Decline

Declining revenue growth can hinder the company's ability to expand and compete, impacting its market position and long-term prospects.

Profitability Challenges

Negative net profit margins suggest operational inefficiencies and could limit reinvestment in business growth and innovation.

Operational Inefficiencies

Declining EBIT and EBITDA margins reflect operational inefficiencies, which may affect the company's ability to sustain profitability.

Modern Healthcare Technology Holdings Limited Business Overview & Revenue Model

Company Description

Modern Healthcare Technology Holdings Limited, an investment holding company, provides beauty and wellness services in Hong Kong, the People's Republic of China, Singapore, and Australia. The company operates in two segments, Beauty and Wellness Services, and Skincare and Wellness Products. It offers beauty and facial services; aesthetics services, such as skincare treatment, professional consultation, skin care and anti-ageing, and referral services on plastic reconstruction; slimming services, including weight management programs; and spa and massage services comprising resplendent bathroom furnishings and a hydrotherapeutic pool, as well as foot spa, foot treatment, and foot massage services. The company also sells skincare and wellness products under the be, FERRECARE, p.e.n, Y.U.E., Advanced Natural, Malu Wilz, Byotea, Care Plus, Cellnoc, Mu-lan Spa, Cellnoc, Veribe, Castille, Dr Plus, Eclat du teint, and Natural Care brand names. In addition, it provides franchise and trademark services in relation to beautification and gymnastic services; advertising services; maid agency services; and management services, as well as food and beverage services. As of March 31, 2022, the company had 30 service centers in Hong Kong; 3 service centers in Mainland China; and 7 service centers in Singapore, as well as 8 be Beauty Shop outlets. Modern Healthcare Technology Holdings Limited is headquartered in Kowloon Bay, Hong Kong.

How the Company Makes Money

The company generates revenue through multiple streams, primarily by selling its healthcare technology products and services to hospitals, clinics, and other healthcare facilities. This includes software licensing fees, subscription services for ongoing support, and maintenance contracts. Additionally, Modern Healthcare Technology Holdings Limited may engage in partnerships with other technology firms and healthcare organizations, leading to collaborative projects that can enhance its service offerings and increase revenue. The company may also benefit from government contracts or grants aimed at improving healthcare technology infrastructure, further contributing to its financial growth.

Modern Healthcare Technology Holdings Limited Financial Statement Overview

Summary

Mixed fundamentals: income statement weakness (declining revenue growth and negative net margins; deteriorating EBIT/EBITDA margins) is partially offset by better cash generation (strong free cash flow growth and positive cash conversion) and improved leverage, though ROE remains negative.

Income Statement

The company has experienced declining revenue growth, with a negative growth rate in the most recent year. Gross profit margins remain healthy, but net profit margins are negative, indicating profitability challenges. EBIT and EBITDA margins have also declined significantly, suggesting operational inefficiencies.

Balance Sheet

The debt-to-equity ratio has improved, indicating better leverage management. However, the return on equity is negative, reflecting ongoing profitability issues. The equity ratio remains stable, suggesting a solid asset base relative to equity.

Cash Flow

The company has shown strong free cash flow growth, indicating improved cash generation capabilities. The operating cash flow to net income ratio is positive, suggesting efficient cash conversion, although the free cash flow to net income ratio indicates room for improvement.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	455.00M	453.27M	454.71M	406.33M	355.59M	431.45M
Gross Profit	113.55M	165.26M	166.96M	394.72M	341.52M	417.67M
EBITDA	70.63M	77.11M	95.68M	70.72M	26.39M	240.65M
Net Income	-5.07M	-5.07M	-9.57M	-20.61M	-68.81M	125.72M
Balance Sheet
Total Assets	564.46M	564.46M	611.04M	561.35M	570.96M	669.04M
Cash, Cash Equivalents and Short-Term Investments	236.67M	236.67M	193.66M	177.53M	127.53M	234.34M
Total Debt	68.65M	68.65M	106.57M	40.11M	65.01M	115.07M
Total Liabilities	373.26M	373.26M	416.65M	357.47M	347.75M	376.15M
Stockholders Equity	185.85M	185.85M	189.33M	199.77M	219.58M	289.37M
Cash Flow
Free Cash Flow	134.94M	134.94M	64.08M	125.52M	-29.55M	121.64M
Operating Cash Flow	151.09M	151.09M	78.66M	139.82M	51.31M	123.88M
Investing Cash Flow	-24.70M	-50.50M	8.16M	-13.17M	-79.96M	-2.85M
Financing Cash Flow	-66.24M	-66.24M	-70.60M	-77.31M	-78.46M	-77.89M

Modern Healthcare Technology Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.08
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0919, the sentiment is Positive. The current price of 0.08 is below the 20-day moving average (MA) of 0.09, below the 50-day MA of 0.08, and below the 200-day MA of 0.08, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 52.81 is Neutral, neither overbought nor oversold. The STOCH value of 37.02 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0919.

Modern Healthcare Technology Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
8603	66 Neutral	HK$5.45B	106.06	49.25%	―	56.28%	-9.91%
0922	62 Neutral	HK$255.46M	9.20	2.99%	9.17%	-7.05%	-43.44%
Sector *	61 Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
0919	59 Neutral	HK$85.93M	4.82	10.10%	―	-3.40%	515.63%
1827	57 Neutral	HK$316.00M	29.04	7.67%	―	-20.59%	―
6966	55 Neutral	HK$475.00M	-65.07	-3.06%	1.10%	-38.66%	-161.86%
8296	48 Neutral	HK$32.13M	-6.18	-3.96%	―	15.60%	62.35%

Modern Healthcare Technology Holdings Limited Corporate Events

Modern Healthcare Technology Updates Cayman Islands Office Addresses

Modern Healthcare Technology Holdings Limited has announced a change in the addresses of its Cayman Islands share registrar and transfer office, as well as its registered office, effective from December 9, 2025. This change is part of the company’s operational updates, with the Hong Kong share registrar remaining unchanged, indicating a strategic move to streamline their operations without affecting their Hong Kong-based activities.

The most recent analyst rating on (HK:0919) stock is a Hold with a HK$0.07 price target. To see the full list of analyst forecasts on Modern Healthcare Technology Holdings Limited stock, see the HK:0919 Stock Forecast page.

Modern Healthcare Technology Reports Positive Interim Results

Modern Healthcare Technology Holdings Limited announced its unaudited consolidated interim results for the six months ending September 30, 2025, reporting a profit of HK$6.946 million, a significant improvement from a loss of HK$16.125 million in the same period last year. This positive turnaround is attributed to reduced costs across various operational areas, despite a slight decrease in revenue, indicating improved operational efficiency and a stronger financial position for the company.

The most recent analyst rating on (HK:0919) stock is a Hold with a HK$0.07 price target. To see the full list of analyst forecasts on Modern Healthcare Technology Holdings Limited stock, see the HK:0919 Stock Forecast page.

Modern Healthcare Technology Holdings Announces Positive Profit Turnaround

Modern Healthcare Technology Holdings Limited has announced a positive profit alert, indicating an expected profit of no less than HKD 5 million for the six months ending September 2025, compared to a loss of about HKD 16 million in the same period last year. This financial turnaround is attributed to the company’s successful implementation of lean management strategies, resulting in reduced labor costs, which may positively impact its market positioning and stakeholder confidence.

Modern Healthcare Technology Holdings Announces Upcoming Board Meeting

Modern Healthcare Technology Holdings Limited has announced an upcoming board meeting scheduled for November 28, 2025, in Hong Kong. The meeting will address the approval of the interim results for the six months ending September 30, 2025, and consider the payment of an interim dividend. This announcement signifies the company’s ongoing commitment to transparency and shareholder engagement, potentially impacting its financial strategy and stakeholder relations.